Literature DB >> 3012285

Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections.

M G Revello, E Percivalle, G Gerna.   

Abstract

Thirty-two patients with primary human cytomegalovirus (HCMV) infection were examined for presence of antibody to the membrane (Me) of uninfected human embryonic lung fibroblasts (HELF) using an anti-complement immunofluorescence (ACIF) test. Patients were divided into three groups according to age: less than or equal to 12 months (11 cases), 2-6 years (8 cases), greater than or equal to 13 years (13 cases). Convalescent-phase sera from 13 out of 13 of the older and 6 out of 8 of the middle-aged group gave positive fluorescence staining of the membrane of living uninfected HELF monolayers, whereas only one out of 11 younger patients showed antibody reactivity to HELF Me. ACIF performed on IgM and IgG fractions of randomly selected Me antibody-positive sera, showed a reactivity to HELF Me restricted to antibody of the IgM class (Me IgM). HELF Me IgM were first detected during the second week after the onset of symptoms of primary HCMV infection and disappeared usually within 4-6 months. Me IgM were not detected in sera from patients with HCMV infections other than primary (i.e. recurrent or congenital), or with other herpesvirus infections and were not detected in sera from patients with severe immunological diseases. HELF Me IgM were shown not to be related to rheumatoid factor and their reactivity was shown to be restricted to HELF cells, for it was not observed in any of the other cell types tested. The determination of HELF Me IgM antibody appears to be a new, practical and useful serological tool for the diagnosis of primary infections in patients over 2 years.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012285

Source DB:  PubMed          Journal:  Microbiologica        ISSN: 0391-5352


  4 in total

1.  Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.

Authors:  J Basson; J C Tardy; M Aymard
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays.

Authors:  A E Greijer; J M van de Crommert; S J Stevens; J M Middeldorp
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Lack of correlation between virus detection and serologic tests for diagnosis of active cytomegalovirus infection in patients with AIDS.

Authors:  T Lazzarotto; P Dal Monte; M C Boccuni; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.